Geldanamycin, a specific Hsp90 inhibitor, causes misfolding and increases proteasomal degradation of hERG, which can cause long QT syndrome, resulting in ventricular arrhythmias and even death (Vandenberg et al., 2001; Ficker et al., 2003). Here, KCNH2 is linked to Ventricular arrhythmia.